Dehydro isradipine
CAS: 116169-18-7
Ref. 3D-FD20919
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Información del producto
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester4-(4-Benzofurazanyl)-2,6-dimethyl -3,5-pyridinedicarboxylic acid methyl 1-methylethyl esterPN 203-831
- 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- 4-(4-Benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester
- Dehydro Isradipine
- Methyl Propan-2-Yl 4-(2,1,3-Benzoxadiazol-4-Yl)-2,6-Dimethylpyridine-3,5-Dicarboxylate
Dehydro isradipine is a high performance liquid chromatography (HPLC) method for the analysis of isradipine. It was developed as an alternative to the standard reversed-phase HPLC method. The HPLC method has been validated and found to be superior in terms of sensitivity, linearity, and capability for quantification. Dehydro isradipine can be analyzed by reversed-phase or liquid chromatography methods. Dehydro isradipine inhibits cytochrome P450 enzymes, which are involved in the metabolism of many drugs, thus affecting their efficacy. This inhibition may lead to adverse drug reactions or reduced therapeutic effect.
Propiedades químicas
Consulta técnica sobre: 3D-FD20919 Dehydro isradipine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.